The ranking
No public survey ranks medtech functions by total effort, so we combined cost, time, and volume data into our own ranking:
| Rank | Workload | Why it is heavy | Key figure |
|---|---|---|---|
| 1 | EU MDR and IVDR compliance | New clinical and postmarket documents, long notified body reviews, recurring certification fees | About €498,000 in costs per device over five years, excluding internal costs (MedTech Europe) |
| 2 | CAPA, complaint handling, and design controls | The quality system areas FDA cites most | CAPA, design controls, and complaints were the top three warning letter citations in FY2025 |
| 3 | US premarket submissions | Testing, documentation, and FDA questions | 80% of companies need a month or more to prepare a 510(k); 24% need more than six months (2025 industry benchmark) |
| 4 | Postmarket reporting and recalls | High report volumes and urgent recall work | FDA receives more than 2 million medical device reports a year |
| 5 | Labeling and promotional review | Many product variants, languages, and markets | McKinsey reports 20 to 30% productivity gains where AI is used for labeling |
As in pharma, the common thread is documents: technical files, clinical evaluations, design history files, complaint records, and labels. The difference is that in medtech the load is spread more evenly across the product’s life, from design to postmarket.
Premarket: US submissions and EU certification
United States.
- In a 2025 industry benchmark of 130 regulatory professionals:
- 80% need a month or more to prepare a 510(k), and 24% need more than six months.
- 61% cite heavy administrative burden.
- 67% still track time to market partly or fully by hand.
- FDA review data under MDUFA V shows that original PMAs and panel-track supplements rose from 69 in FY2024 to 89 in FY2025. The share not accepted on the first cycle fell from 12.3% (FY2023) to 6.8% (FY2025).
European Union: the heaviest single load.
- More documents. The MDR added about 15 new clinical and postmarket reports compared with the old directives. A majority of MedTech Europe survey respondents say maintaining them can take up to four months each year.
- Clinical evaluation. Half of respondents had a clinical evaluation significantly challenged by their notified body.
- Slow reviews. Notified bodies say MDR certification typically takes 13 to 18 months. In an earlier Commission survey, 58% of that time was spent waiting on the manufacturer.
- Incomplete files. Team-NB says 65% of MDR files submitted lack at least half the required information. Incomplete applications were the top reason for refusals (39%).
- Cost. MedTech Europe estimates about €212,000 per quality system certificate and €342,000 per technical documentation certificate at recertification, and about €498,000 per device over five years, excluding internal costs. These figures come from a small sample (more than 15 respondents).
- Market effects. In an EY study for the Commission, 57% of companies had reduced their device portfolios and 24% had stopped producing some devices for the EU.
As of 28 February 2026, notified bodies had received 32,898 MDR applications and issued 18,010 certificates.
Quality system and postmarket
The quality system is where FDA finds the most problems.
[Chart: ECA Academy analysis of FDA device warning letters, FY2025 (published 6 Nov 2025). See the live document for the chart.]
- Form 483 observations. A 2026 MD+DI panel put CAPA at 12.4%, design controls at 12.3%, and complaints at 10.6%. Together that is more than a third of all observations, though no time period was given.
- New rule. Since 2 February 2026, FDA’s Quality Management System Regulation (QMSR) has incorporated ISO 13485 by reference, with some added FDA requirements such as records and labeling controls.
Postmarket volume is large.
| Measure | Figure | Source |
|---|---|---|
| Medical device reports (MDRs) to FDA | more than 2 million a year, mostly malfunctions | Federal Register, 2024 |
| Electronic submissions to FDA’s device center | 4,664,504 in 2025, up from 812,443 in 2014 | FDA ESG statistics |
| Device recall events, first half of 2025 | 487 (538 in the first half of 2024) | Sedgwick |
| Class I recall events, Q2 2025 | 36, the most in a quarter for 20 years | Sedgwick |
| EU postmarket clinical follow-up study | about 2 years | MedTech Europe |
Each complaint can lead to an investigation, an MDR decision, a CAPA, and sometimes a recall. One customer issue can therefore create work in several systems at once.
Where AI and automation help
- Productivity potential. McKinsey (2025) puts generative AI’s productivity potential in medtech at $14 to 55 billion a year. Companies using AI for labeling report 20 to 30% productivity gains, and about a third use it to speed marketing content and medical and legal review.
- Technical documents. BCG (2025) projects that generative AI could cut first-draft time for technical documents by 40 to 60%. However, only 10% of medtech companies report value from generative AI so far.
- Best targets. These are the document-heavy workloads above: EU technical files and clinical evaluations, 510(k) sections, complaint and CAPA records, and labels. AI drafts and checks consistency; people stay accountable for regulatory and safety decisions.
Using this in AI and RAG
- Index the rules behind each workload: QMSR and ISO 13485, 21 CFR 803 and 807, EU MDR and IVDR annexes, and MDCG guidance.
- Index your own records by workload: technical files, design history files, complaints, CAPAs, and labeling.
- Link complaints to MDR reports, CAPAs, and recalls so one issue can be traced across systems.
- Measure before and after: preparation time, notified body questions, and the number of open CAPAs.
Common mistakes
- Submitting incomplete EU files, the top reason for refusal.
- Treating complaints, MDR reports, and CAPAs as separate silos.
- Tracking regulatory timelines by hand.
- Using AI drafts without traceable sources.
Checklist
- Workloads ranked by hours and cost in your own company
- Rules and records indexed per workload
- Complaint, MDR, CAPA, and recall records linked
- Baseline metrics captured
How AskDona helps
AskDona targets the document-heavy part of these workloads. It checks technical files, clinical evaluations, 510(k) sections, complaint and CAPA records, and labels against the rules and your own source documents, and cites the passage behind each finding.
Run a sample technical file evidence check
AskDona shows the evidence; your regulatory, quality, and clinical teams decide.
Editor’s note. This article is general information. The ranking is our editorial judgment based on the cited data, because no public source ranks medtech functions by total effort. EU cost figures are self-reported by industry from a small sample. The warning letter breakdown is a third-party analysis.
FAQ
What is the heaviest workload in medtech? For companies selling in Europe, EU MDR and IVDR compliance: about 15 new reports, up to four months a year to maintain them, and about €498,000 per device over five years.
What does FDA cite most often? CAPA, design controls, and complaint files. These were the top three citations in FY2025 device warning letters.
How long does a 510(k) take to prepare? 80% of companies need a month or more, and 24% need more than six months (2025 industry benchmark).
How many adverse event reports does FDA receive for devices? More than 2 million medical device reports a year.
References
All pages opened and checked by October 30, 2026.